10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.
CIK: 1697884
File #: 333-216645
Balance Sheet
35 line items · 2 periods
XBRL
| Item | Oct 31, 2023 | Jan 31, 2023 |
|---|---|---|
BALANCE SHEETS | ||
CURRENT ASSETS | ||
Cash | 2,636 | 29,656 |
Accounts Receivable | 60,000 | 380,000 |
Other Non-Operating Current Assets | 5,364 | 27,422 |
Other Current Assets | 38,308 | 0 |
Total current assets | 106,308 | 437,078 |
LONG-TERM ASSETS | ||
Property, Plant and Equipment | 38,277 | 49,574 |
Operating Lease Right-of-Use Asset | 132,764 | 255,682 |
Other Non-Current Assets | 0 | 23,614 |
Total long-term assets | 171,041 | 328,870 |
Total assets | 277,349 | 765,948 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
CURRENT LIABILITIES | ||
Accounts payable - related party | 2,411,000 | 2,411,000 |
Accounts Payable | 316,507 | 55,063 |
Taxes Payable | 218,714 | 218,714 |
Operating Lease Liability, Current | 138,287 | 169,647 |
Advances from related party | 358,849 | 214,682 |
Total current liabilities | 3,443,357 | 3,069,106 |
LONG-TERM LIABILITY | ||
Operating Lease Liability, Current | 0 | 93,334 |
Total long-term liability | 0 | 93,334 |
Total liabilities | 3,443,357 | 3,162,440 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' DEFICIT | ||
Total Stockholders' Equity | 20,703 | 20,703 |
Total Stockholders' Equity | 1,094,472 | 970,824 |
Total Stockholders' Equity | (4,281,183) | (3,388,019) |
Total stockholders' deficit | (3,166,008) | (2,396,492) |
Retained Earnings (Accumulated Deficit) | (4,281,183) | (3,388,019) |
Additional Paid-In Capital | 1,094,472 | 970,824 |
Common Stock | 20,703 | 20,703 |
Total liabilities and stockholders' deficit | 277,349 | 765,948 |